Rianne E. van Rijswijk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rianne E. van Rijswijk has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Erik Groot Jebbink
Department of Vascular Surgery, Rijnstate, Arnhem, The Netherlands; Multi-Modality Medical Imaging Group, Technical Medical Centre, University of Twente, Enschede, The Netherlands
3 shared publications- Erik Groot Jebbink
Multi-Modality Medical Imaging Group, University of Twente, Enschede, The Netherlands
3 shared publications - Michel M. P. J. Reijnen
Department of Surgery, Rijnstate Hospital, Arnhem, the Netherlands
3 shared publications Michel M.P.J. Reijnen
Multi-Modality Medical Imaging (M3I) Group, TechMed Centre, University of Twente, Enschede, the Netherlands; Department of Vascular Surgery, Rijnstate, Arnhem, the Netherlands
3 shared publicationsClark J. Zeebregts
Department of Surgery, Division of Vascular Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
2 shared publicationsJelmer M. Wolterink
University of Twente
2 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (12) , 2859-2869
Comparison of 3‐Dimensional Ultrasound and Computed Tomography for Imaging of Abdominal Aortic Aneurysms
Objectives: Three‐dimensional ultrasound (3D US) is emerging as a novel imaging method for abdominal aortic aneurysms (AAAs) as it creates a low‐cost 3D AAA overview without harmful radiation and nephrotoxic contrast agents, as opposed to conventional imaging. 3D US can be used with a non‐nephrotoxic contrast agent (3D‐CEUS) for lumen delineation. This study aims to compare 3D US and 3D‐CEUS using a commercially available 3D US system against contrast‐enhanced computed tomography (CTA). Methods: For twenty AAA patients, the total AAA was segmented for all 3 modalities, and the lumen was segmented in the 3D‐CEUS and CTA scans. The CTA segmentations were registered onto each 3D (CE)US segmentation, and evaluation metrics were computed, including the volumes, average surface distance, sensitivity, precision, and Dice score. Results: 3D US and 3D‐CEUS scans were feasible in all patients. Lumen volumes were significantly larger on 3D‐CEUS compared to CTA (94 versus 70 mL, p < .001). The total AAA volumes were significantly smaller on 3D US compared to CTA (142 versus 165 mL, p = .002), and comparable on 3D‐CEUS (176 versus 165 mL, p = .433). The Dice scores were overall acceptable, ranging from 0.82 to 0.88, and the average surface distances were 2.5 mm. Conclusions: This study demonstrated the feasibility of 3D US and 3D‐CEUS for AAA imaging with good correspondence to CTA. Addition of the contrast agent increased agreement of volume measurements. 3D US facilitated retrospective offline AAA assessment, which is a major added value compared to 2D US. For now, 3D US already seems a promising imaging modality, which has to be proven in a large‐scale study.
- 3 August 2026
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (12) , 2859-2869
Open AccessComparison of 3‐Dimensional Ultrasound and Computed Tomography for Imaging of Abdominal Aortic Aneurysms
Objectives: Three‐dimensional ultrasound (3D US) is emerging as a novel imaging method for abdominal aortic aneurysms (AAAs) as it creates a low‐cost 3D AAA overview without harmful radiation and nephrotoxic contrast agents, as opposed to conventional imaging. 3D US can be used with a non‐nephrotoxic contrast agent (3D‐CEUS) for lumen delineation. This study aims to compare 3D US and 3D‐CEUS using a commercially available 3D US system against contrast‐enhanced computed tomography (CTA). Methods: For twenty AAA patients, the total AAA was segmented for all 3 modalities, and the lumen was segmented in the 3D‐CEUS and CTA scans. The CTA segmentations were registered onto each 3D (CE)US segmentation, and evaluation metrics were computed, including the volumes, average surface distance, sensitivity, precision, and Dice score. Results: 3D US and 3D‐CEUS scans were feasible in all patients. Lumen volumes were significantly larger on 3D‐CEUS compared to CTA (94 versus 70 mL, p < .001). The total AAA volumes were significantly smaller on 3D US compared to CTA (142 versus 165 mL, p = .002), and comparable on 3D‐CEUS (176 versus 165 mL, p = .433). The Dice scores were overall acceptable, ranging from 0.82 to 0.88, and the average surface distances were 2.5 mm. Conclusions: This study demonstrated the feasibility of 3D US and 3D‐CEUS for AAA imaging with good correspondence to CTA. Addition of the contrast agent increased agreement of volume measurements. 3D US facilitated retrospective offline AAA assessment, which is a major added value compared to 2D US. For now, 3D US already seems a promising imaging modality, which has to be proven in a large‐scale study.
- Open Access
- 5 August 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (6) , 2023-2035
Anatomical characteristics are associated with aneurysm sac regression after endovascular repair
- 5 August 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (6) , 2023-2035
Open AccessAnatomical characteristics are associated with aneurysm sac regression after endovascular repair
- Open Access
- 19 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (3) , 386-396
Impact of Endograft Fabric on Aneurysm Sac Remodelling after Elective Infrarenal Endovascular Aneurysm Repair
- 19 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (3) , 386-396
Open AccessImpact of Endograft Fabric on Aneurysm Sac Remodelling after Elective Infrarenal Endovascular Aneurysm Repair
- 13 March 2025
- Published by SAGE Publications in Vascular
- Vol. 34 (1) , 69-78
Feasibility of tomographic freehand three-dimensional ultrasound for surveillance of abdominal aortic aneurysms after endovascular repair
Objectives: This study aimed to investigate the feasibility of a commercially available tomographic freehand three-dimensional ultrasound (3D-US) system for surveillance of abdominal aortic aneurysms (AAAs) after endovascular repair (EVAR). Methods: In 10 patients who underwent EVAR, a 3D-US scan was obtained post-operatively in addition to regular computed tomography angiography (CTA). Five independent observers evaluated 12 EVAR surveillance parameters for the 10 scans, resulting in a total of 600 individual observations. Results: The diameters of the neck, sac and iliac arteries were evaluable in most of the observations (neck: 80%, AAA sac: 98%, right CIA: 90%, left CIA: 68%). The diameter measurements of the 3D-US strongly correlated with the diameters measured on CTA ( ρ = 0.90, p < .001). The general offset of 3D-US compared to CTA was −4.4 mm and the proportional bias was 3%. For all observers, the diameter measurements were significantly strongly correlated (O1:ρ = 0.85, O2:ρ = 0.88, O3:ρ = 0.93, O4:ρ = 0.96, O5:ρ = 0.86, p < .001 for all). The inter-observer reliability was excellent with an overall concordance correlation coefficient of 0.98. The start of the endograft, the lowest renal artery, the distance between these landmarks, and the proximal and distal sealing zones were evaluable in fewer than half of the observations (42%, 12%, 10%, 32%, 32%, 26%). Conclusion: 3D-US after EVAR is feasible. Diameters measured in 3D-US correlate strongly with CTA-based diameters and have a good interrater variability. However, the sealing zones are difficult to assess on 3D-US. This technique could be a useful addition to duplex ultrasound to facilitate offline 3D analysis, increase measurement reproducibility, enable volume measurements, and minimise the use of harmful CTA for surveillance after EVAR.
- 13 March 2025
- Published by SAGE Publications in Vascular
- Vol. 34 (1) , 69-78
Feasibility of tomographic freehand three-dimensional ultrasound for surveillance of abdominal aortic aneurysms after endovascular repair
Objectives: This study aimed to investigate the feasibility of a commercially available tomographic freehand three-dimensional ultrasound (3D-US) system for surveillance of abdominal aortic aneurysms (AAAs) after endovascular repair (EVAR). Methods: In 10 patients who underwent EVAR, a 3D-US scan was obtained post-operatively in addition to regular computed tomography angiography (CTA). Five independent observers evaluated 12 EVAR surveillance parameters for the 10 scans, resulting in a total of 600 individual observations. Results: The diameters of the neck, sac and iliac arteries were evaluable in most of the observations (neck: 80%, AAA sac: 98%, right CIA: 90%, left CIA: 68%). The diameter measurements of the 3D-US strongly correlated with the diameters measured on CTA ( ρ = 0.90, p < .001). The general offset of 3D-US compared to CTA was −4.4 mm and the proportional bias was 3%. For all observers, the diameter measurements were significantly strongly correlated (O1:ρ = 0.85, O2:ρ = 0.88, O3:ρ = 0.93, O4:ρ = 0.96, O5:ρ = 0.86, p < .001 for all). The inter-observer reliability was excellent with an overall concordance correlation coefficient of 0.98. The start of the endograft, the lowest renal artery, the distance between these landmarks, and the proximal and distal sealing zones were evaluable in fewer than half of the observations (42%, 12%, 10%, 32%, 32%, 26%). Conclusion: 3D-US after EVAR is feasible. Diameters measured in 3D-US correlate strongly with CTA-based diameters and have a good interrater variability. However, the sealing zones are difficult to assess on 3D-US. This technique could be a useful addition to duplex ultrasound to facilitate offline 3D analysis, increase measurement reproducibility, enable volume measurements, and minimise the use of harmful CTA for surveillance after EVAR.
- Open Access
- 30 January 2025
- Published by SAGE Publications in Journal of Endovascular Therapy
Multimodal Artificial Intelligence Model for Prediction of Abdominal Aortic Aneurysm Shrinkage After Endovascular Repair ( the ART in EVAR study)
Purpose: The goal of the study described in this protocol is to build a multimodal artificial intelligence (AI) model to predict abdominal aortic aneurysm (AAA) shrinkage 1 year after endovascular aneurysm repair (EVAR). Methods: In this retrospective observational multicenter study, approximately 1000 patients will be enrolled from hospital records of 5 experienced vascular centers. Patients will be included if they underwent elective EVAR for infrarenal AAA with initial assisted technical success and had imaging available of the same modality preoperatively and at 1-year follow-up (CTA-CTA or US-US). Data collection will include baseline and vascular characteristics, medication use, procedural data, preoperative and postoperative imaging data, follow-up data, and complications. Proposed Analyses: The cohort will be stratified into 3 groups of AAA remodeling based on the maximum AAA diameter difference between the preoperative and 1-year postoperative moment. Patients with a diameter reduction of ≥5 mm will be assigned to the AAA shrinkage group, cases with an increase of ≥5 mm will be assigned to the AAA growth group, and patients with a diameter increase or reduction of <5 mm will be assigned to the stable AAA group. Furthermore, an additional fourth group will include all patients who underwent an AAA-related reintervention within the first year after EVAR, because both the complication and the reintervention might have influenced the state of AAA remodeling at 1 year. The preoperative and postoperative CTA scans will be used for anatomical AAA analysis and biomechanical assessment through semi-automatic segmentation and finite element analysis. All collected clinical, biomechanical, and imaging data will be used to create an AI prediction model for AAA shrinkage. Explainable AI techniques will be used to identify the most descriptive input features in the model. Predicting factors resulting from the AI model will be compared with conventional univariate and multivariate logistic regression analyses to find the best model for the prediction of AAA shrinkage. The study is registered at www.clinicaltrials.gov under the registration number NCT06250998. Clinical Impact: This study aims to develop a robust and high-performance AI model for predicting AAA shrinkage one-year after EVAR, with great potential for optimizing both EVAR treatment and follow-up. The model can identify cases with an initially lower chance of early AAA shrinkage, in whom EVAR-treatment could be tailored by including additional preoperative coil embolization, active sac management and/or postoperative tranexamic acid therapy, which have shown to promote AAA shrinkage rate but are too complex and costly to perform in all patients. The model could aid in stratification of post-EVAR surveillance based on the patient’s individual risk and possibly decrease follow-up for the 40-50% of patients who will experience AAA sac shrinkage. Overall, the AI prediction model is expected to improve patient survival and decrease the number of reinterventions after EVAR and associated healthcare costs.
- 30 January 2025
- Published by SAGE Publications in Journal of Endovascular Therapy
Open AccessMultimodal Artificial Intelligence Model for Prediction of Abdominal Aortic Aneurysm Shrinkage After Endovascular Repair ( the ART in EVAR study)
Purpose: The goal of the study described in this protocol is to build a multimodal artificial intelligence (AI) model to predict abdominal aortic aneurysm (AAA) shrinkage 1 year after endovascular aneurysm repair (EVAR). Methods: In this retrospective observational multicenter study, approximately 1000 patients will be enrolled from hospital records of 5 experienced vascular centers. Patients will be included if they underwent elective EVAR for infrarenal AAA with initial assisted technical success and had imaging available of the same modality preoperatively and at 1-year follow-up (CTA-CTA or US-US). Data collection will include baseline and vascular characteristics, medication use, procedural data, preoperative and postoperative imaging data, follow-up data, and complications. Proposed Analyses: The cohort will be stratified into 3 groups of AAA remodeling based on the maximum AAA diameter difference between the preoperative and 1-year postoperative moment. Patients with a diameter reduction of ≥5 mm will be assigned to the AAA shrinkage group, cases with an increase of ≥5 mm will be assigned to the AAA growth group, and patients with a diameter increase or reduction of <5 mm will be assigned to the stable AAA group. Furthermore, an additional fourth group will include all patients who underwent an AAA-related reintervention within the first year after EVAR, because both the complication and the reintervention might have influenced the state of AAA remodeling at 1 year. The preoperative and postoperative CTA scans will be used for anatomical AAA analysis and biomechanical assessment through semi-automatic segmentation and finite element analysis. All collected clinical, biomechanical, and imaging data will be used to create an AI prediction model for AAA shrinkage. Explainable AI techniques will be used to identify the most descriptive input features in the model. Predicting factors resulting from the AI model will be compared with conventional univariate and multivariate logistic regression analyses to find the best model for the prediction of AAA shrinkage. The study is registered at www.clinicaltrials.gov under the registration number NCT06250998. Clinical Impact: This study aims to develop a robust and high-performance AI model for predicting AAA shrinkage one-year after EVAR, with great potential for optimizing both EVAR treatment and follow-up. The model can identify cases with an initially lower chance of early AAA shrinkage, in whom EVAR-treatment could be tailored by including additional preoperative coil embolization, active sac management and/or postoperative tranexamic acid therapy, which have shown to promote AAA shrinkage rate but are too complex and costly to perform in all patients. The model could aid in stratification of post-EVAR surveillance based on the patient’s individual risk and possibly decrease follow-up for the 40-50% of patients who will experience AAA sac shrinkage. Overall, the AI prediction model is expected to improve patient survival and decrease the number of reinterventions after EVAR and associated healthcare costs.
- Open Access
- 1 May 2022
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 75 (5) , 1777-1785
A systematic review of anatomic predictors of abdominal aortic aneurysm remodeling after endovascular repair
- 1 May 2022
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 75 (5) , 1777-1785
Open AccessA systematic review of anatomic predictors of abdominal aortic aneurysm remodeling after endovascular repair
- Open Access
- 3 March 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (5) , 1394
Predictors of Abdominal Aortic Aneurysm Shrinkage after Endovascular Repair
Recent studies demonstrate that patients with a shrinking abdominal aortic aneurysm (AAA), one-year after endovascular repair (EVAR), have better long-term outcomes than patients with a stable AAA. It is not known what factors determine whether an AAA will shrink or not. In this study, a range of parameters was investigated to identify their use in differentiating patients that will develop a shrinking AAA from those with a stable AAA one-year after EVAR. Hundred-seventy-four patients (67 shrinking AAA, 107 stable AAA) who underwent elective, infrarenal EVAR were enrolled between 2011–2018. Long-term survival was significantly better in patients with a shrinking AAA, compared to those with a stable AAA (p = 0.038). Larger preoperative maximum AAA diameter was associated with an increased likelihood of developing AAA shrinkage one-year after EVAR—whereas older age and larger preoperative infrarenal β angle were associated with a reduced likelihood of AAA shrinkage. However, this multivariate logistic regression model was only able to correctly identify 66.7% of patients with AAA shrinkage from the total cohort. This is not sufficient for implementation in clinical care, and therefore future research is recommended to dive deeper into AAA anatomy, and explore potential predictors using artificial intelligence and radiomics.
- 3 March 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (5) , 1394
Open AccessPredictors of Abdominal Aortic Aneurysm Shrinkage after Endovascular Repair
Recent studies demonstrate that patients with a shrinking abdominal aortic aneurysm (AAA), one-year after endovascular repair (EVAR), have better long-term outcomes than patients with a stable AAA. It is not known what factors determine whether an AAA will shrink or not. In this study, a range of parameters was investigated to identify their use in differentiating patients that will develop a shrinking AAA from those with a stable AAA one-year after EVAR. Hundred-seventy-four patients (67 shrinking AAA, 107 stable AAA) who underwent elective, infrarenal EVAR were enrolled between 2011–2018. Long-term survival was significantly better in patients with a shrinking AAA, compared to those with a stable AAA (p = 0.038). Larger preoperative maximum AAA diameter was associated with an increased likelihood of developing AAA shrinkage one-year after EVAR—whereas older age and larger preoperative infrarenal β angle were associated with a reduced likelihood of AAA shrinkage. However, this multivariate logistic regression model was only able to correctly identify 66.7% of patients with AAA shrinkage from the total cohort. This is not sufficient for implementation in clinical care, and therefore future research is recommended to dive deeper into AAA anatomy, and explore potential predictors using artificial intelligence and radiomics.